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Since epidermal Langerhans cells share many of the 
surface marker characteristics and functions of cells of 
the monocyte-macrophage series, we sought to deter-
mine whether Langerhans cells, like macrophages, pro-
duce Interleukin 1 (IL-l), formerly called lymphocyte 
activating factor. Heterogenous suspensions of murine 
epidermal cells were cultured for 3 days with or without 
various stimulants and their cell-free supernatants were 
tested for IL-l activity in a thymocyte proliferation as-
say. Significant augmentation of lectin induced thymo-
cyte proliferation was produced by the supernatants of 
these cultures. However, when epidermal cells were de-
pleted of Langerhans cells by treating with anti-Ia anti-
serum and complement, the supernatants still produced 
significant augmentation. As the augmenting activity 
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CXM: Cycloheximide 
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ET AF: epidermal cell thymocyte activating factor 
FCS: fetal calf serum 
IL-1: interleukin 1 
IL-2: interleukin 2 
LC: Langerhans cells . 
MDP: murarnyl dipeptide 
PHA: phytohemagglutinin 
PMA: phorbol myristic acetate 
SUP: cell free supematants 
was due to a factor found in the supernatants of epider-
mal cell suspensions devoid of Langerhans cells the fac-
tor is called Epidermal Cell Thymocyte Activating Fac-
tor (ETAF). ETAF was produced by unstimulated epi-
dermal cells, but significantly more was produced by 
epidermal cells that were incubated with phorbol myr-
istic acetate, a low molecular weight tumor promoting 
agent or muramyl dipeptide, the synthetic analog of the 
cell wall of mycobacterium smegmatis. ET AF production 
was reduced by X-irradiatiQn and was completely abol-
ished when protein synthesis was inhibited. The molec-
ular weight of this factor was approximately 15,000 dal-
ton, which is similar to the molecular weight of macro-
phage derived IL-I; its heat stability and pH stability 
were similar to that of IL-I. ETAF, like IL-l also en-
hanced lymphocyte production of Interleukin 2 (IL-2). 
The data indicate that epidermal cells, devoid of Langer-
hans cells, are capable of producing factors with IL-I 
like activity and may thereby modulate immune re-
sponses locally in the skin and perhaps systemically. 
The role of t h e macrophage in T-cell activation is mediated 
in part by a 12,000 to 16,000 molecular weight factor called 
lymphocyte activating factor or Interleukin 1 (IL-1) [1- 8]. IL-l 
is capable of enhancing lectin-induced DNA synthesis in th y-
mocytes [5,9] and appears to be involved in peripheral helper 
T cell activation [1-3]. Macrophages produce IL-l in response 
to a wide variety of stimuli including endotoxin, phorbol esters, 
lectin-activated T cells and lymphokines [9-12]. In view of the 
relationship between certain macrophages and epidermal Lan-
gerhans cells (LC) (e.g., both bear receptors for the Fc portion 
of IgG and for C3b, synthesize and express Ia antigens, present 
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antigen to sensitized T cells, are capable of allogeneic T cell 
stimulation and are bone marrow derived [13-17]) we investi-
gated whether LC, like macrophages, produce IL-l. We cultured 
murine epidermal cell suspensions, and determined whether 
the supernatants augmented lectin induced thymocyte prolif-
eration. Our results indicate that heterogenous murine epider-
. mal cell cultures and epidermal cell cultures devoid of Langer-
hans cells produce a factor which closely resembles IL-1 both 
functionally and physicochemically. This factor is called Epi-
dermal Cell Thymocyte Activating Factor (ETAF) . 
MATERIALS AND METHODS 
Mice 
Female BALB/c and A/J mice, 8-10 weeks old, and female C3H/ 
HeJ mice, 4-6 weeks old, were obtained from Jackson Laboratories, 
Bar Harbor, Maine. 
Murine Epidermal Cell Suspensions 
Epidermal cell suspensions were prepared as previously described 
[16]. Briefly, truncal skin of animals was shaved and the skin (epidermis 
and dermis) was removed. The skin was then placed dermal side down 
on moistened filter paper and cut into small pieces. The pieces were 
then floated dermal side down on a 1.0% solution of trypsin (type XI, 
Sigma Chemical Co., St. Louis, Mo.) in phosphate buffered saline 
(PBS) for 1 hr a t 37°C. The pieces of skin were spread dermal side 
down in a PetTi dish, and the loosened epidermis was removed with a 
watchmaker forceps. The exposed basal cell layer was covered with a 
solution of 0.05% DNase I (Worthington Labs, Fl·eehold, N.J.) in PBS 
and rubbed with a glass rod to separate the epidermal cells. Medium 
199 (National Institutes of Health, Bethesda, MD.) supplemented with 
10% heat-inactivated fetal calf serum (FCS) was used to collect and 
wash the cells. The resultant epidermal cell suspension (EC) was 
pelleted and washed 3 times before use (viability >90% by trypan blue 
exclusion) . E lectron microscopic studies revealed that epidermal cell 
suspensions as prepared above contained less than one inflammatory 
cell (granulocytes, lymphocytes, or macrophages) per 400 epidermal 
cells (K. Tamaki, M. Gullino, S. I. Katz, unpublished data). 
Detection of Ia Bearing Epidermal Cells (Langerhans Cells) 
Ia antigens on Langerhans cells were ident ified using the immunoflu-
orescent technique of Tamaki et al [16J with minor modifications. 
Briefly , BALB/c epidermal cells (5 X 10") were incubated with a 1: 10 
dilution of either (BlO.A X A) anti-BlO (anti Ia.8) antiserum or (ASW 
X B10.HIT) anti-A.TL antiserum (as a negative control) (both gener-
ously supplied by Dr. D. Sachs, N.I.H., Bethesda, MD) at 4°C with 
sodium azide 0.2% (final concentration) and then washed 3 t imes in 
Puck's saline (GmCO Laboratories, Grand Island, N.Y.) with 5% FCS. 
The cells were then incubated with a 1: 10 dilution of fluorescein-
isothiocyanate labelled rabbit anti-mouse immunoglobulin (Cappel 
Laboratories, Dowington, Pa.) with sodium azide 0.2% (fi nal concentra-
tion) for 30 min at 4°C and then washed three times in Puck's saline 
with 5% FCS. Viability was assessed using 0.05% ethidium bromide 
(2,7-diamino-10-ethyl-9-phenyl-phenathridium bromide, Sigma Chem-
ical Co. , St. Louis, Mo.) according to the method of Van Rood and 
Ploem [19]. 
Depletion of Ia B earing Cells 
Epidermal cell suspensions were depleted of LC by the following 
technique: EC prepared as previously described and adjusted to a 
concentration of 10 X 107/ ml in Puck's saline (GmCO Laboratories) 
with 10% FCS were incubated with a 1: 50 dilution of anti-Ia antiserum 
(A.TH anti-A.TL) (supplied by Dr. D. Sachs) for 30 min at 4°C. Normal 
mouse serum was used as a control. The cells were washed in Puck's 
saline with 10% FCS and then incubated with a 1: 20 dilution of rabbit 
complement (GIBCO Laboratories) for 30 min at 37°C. Cells were then 
washed 3x in ice cold Puck's saline with 5% FCS and counted. The EC 
suspensions were stained for identification of Ia antigens as previously 
described and the percentage of viable la-positive cells (LC) determined 
(19). 
Factor Product,:on 
Varying numbers of freshly prepared EC (1.0 x 10' to 10 X 107 ) were 
incuba ted for 3 days at 37°C in 1 ml of Medium 199 (N .I.H.) containing 
100 units/ml penicillin and 100 /ig/ ml streptomycin (Microbiological 
Associates, Walkersville, MD), supplemented with 10% FCS (M icrobi-
ological Associates); 2.5 X 10- 5 M 2-mercaptoethanol and 2 roM gluta-
mine (Grand Island Biological Company, Grand Island N.Y.) in a 24 
well tissue culture dish (Costar, Cambridge, Mass.) . In attempts to 
increase factor production, epidermal cells were also incubated with the 
following stimulants: phytohemagglutinin (Well come Laboratories, 
Beckenham, England) 1 /igm / ml; concanavalin A (Calbiochem-Berin-
ger, LaJolla, CAl 20 /igm/ ml; phorbol myristic acetate (Sigma Chemical 
Co. ) 1 /igm/ ml; epidermal growth factor (Collaborative Research Inc., 
Waltham Mass.) 10/igm/ ml; lipopolysaccharide (DIFCO Laboratories, 
Detroit, MI) 25 /igm/ ml; streptolysin-O (DIFCO Laboratories, Detroit, 
MI.) 50 ,.u/ ml; muramyl dipeptide (N-acetyl-muramyl-L-Ala-D-Glu-
NH2 (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) 10- 9 gm/ 
ml cholera toxin (Sigma Chemical Co.) 10- 9 M; anti-H-2 antiserum (B10 
X A) anti-BlO.D2 at a 1 :40 dilution and anti-Ia antiserum (A.TH anti-
A.TL) at a 1 :40 dilution. The resultant supernatants were then tested 
for their ability to augment lectin induced thymocyte proliferation as 
described below. 
Thymocyte Proliferation Assay 
Cell-free supernatants (SUP) were dialyzed overnight against 50 vol 
of RPMI 1640 and then sterilized by Millipore filtration. Sanlples were 
assayed for augmentation of lectin induced thymocyte proliferation 
using the assay of Mizel, Oppenheim, and Rosenstreich [10]. Briefly 1.5 
X 106 C3H/ HeJ thymocytes were cultured for 72 hr in Costar flat 
bottom tissue culture plates in 100 ,.u of RPMI 1640 containing 10% 
FCS, penicillin, streptomycin, glutamine, 2.5 X 10-& M 2-mercaptoeth-
anol, 1 /ig/ ml PHA and a 1: 4 dilution of the samples to be tested. 
Cultures were pulsed with 0.5 /i Ci 3H-TdR (1.9 Ci/mM, New England 
Nuclear) for the final 6 hr. Cells were then collected on filter paper 
with the aid of a Mash II harvester (Microbiological Associates, Be· 
thesda, Md.) and the 3H activity on filter discs counted in a scintillation 
counter. The results are expressed as the mean cpm 3H-TdR incorpo-
rated ± SE of triplicate cultw·es. 
Effect of Ionizing Radiation and Cycloheximide Treatment of EC on 
ETAF Production 
EC were exposed to 2,000 R, washed once and after 72 ill· the 
supernatant was tested for ETAF activity. In other experiments we 
treated EC with 10 ~m/ml of cycloheximide (CXM) (Sigma Chemical 
Company) during the initial incubation. The supernatant was then 
removed and dialyzed against RPMI 1640. CXM was added to RPMI 
1640 or to a SUP with known ETAF activity and then dialyzed to 
determine whether CXM alone at these concentrations affected thy-
mocyte proliferation. 
Ammonium Sulfate Precipitation 
Sufficient solid ammonium sulfate was added to the test supernatants 
to obtain a satw·ation of 25%. The solution was incubated for 1 hr at 
4°C. The resultant precipitate was then removed by centrifugation and 
saved for la ter assessment of ETAF activity. Sufficient ammonium 
sulfate was then added to the remaining supernatant to achieve a 45% 
saturation. The solution was mixed and incubated at 4°C. The resultant 
precipitate was removed by centrifugation. The above procedure was 
then repeated to achieve 65, 85, and 100% satw·ation. The pellets were 
redissolved in RPMI 1640 and dialyzed against 3 changes in RPMI 1640 
before assaying for ETAF activity. 
fL ·1 Production 
Mw·ine macrophage derived IL-l was prepared by Dr. Y. Chou, 
N.I.H., Bethesda, MD. using the superinduction method of Mizel and 
Mizel [20]. 
Simultaneous Stimulation of Thymocytes with fL·1 and ETAF 
In order to evaluate whether IL-1 and ETAF were synergistic, 
additive or inhibitory, dilutions of IL-1 and ETAF containing submax-
imal activity in the thymocyte assay were tested alone and together at 
varying dilutions for activity in the thymocyte assay. 
Column Chromatography 
The supernatants from the cultured EC were concentrated 30x using 
Amicon ultrafiltration cells with PM-10 Diaflo membranes (Amicon 
Corporation, Lexington, Mass.). All chromatography was carried out at 
4°C. The column was equilibrated in 50 mM Tris buffered 100 mM NaCI 
(pH 7.5) with 50 /ig/ ml gentamicin (Schering Corporation, Kenilworth 
N.J.) Three ml of concentrated SUP from EC were applied to 2.5 X 95 
cm Sephacryl S-200 (Pharmacia Fine Chemicals, Piscataway, N.J.) 
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columns using reverse flow. This column was calibrated with the 
following markers: aldolase (M.W. 158,(00), ovalbumin (M.W. 67,(00), 
ribonuclease A (M.W. 13,700), myoglobin (M.W. 16,900), and cyto-
chrome C (M.W. 12,384). A flow rate of 20 ml/hr was used and 4 ml 
fractions were collected. Aliquots of the fractions were then diluted 1: 2 
with RPMI 1640, filter sterilized and tested in the thymocyte prolifer-
ation assay. 
In addition to the Sephacryl S-2OO column, 3 ml of concentrated EC 
SUP were applied to a 1 X 95 em Sephadex G-50 superfine column 
(Pharmacia Fine Chemicals) using reverse flow. A flow rate of 7.2 mll 
hr was used and 3.6 ml fractions were collected. Fractions were diluted 
1: 2 with RPMI 1640, filter sterilized, and tested in the thymocyte 
proliferation assay. 
Biologic Assay for Interleukin 2 
Epidermal cell supernatants were tested for Interleukin 2 (IL-2) 
activity by a modification of the method of Gillis et al [21]. Briefly, IL-
2 dependent C57BL/6 derived T cells (CT6 cells) were washed 2x with 
RPMI 1640 medium and adjusted to a density of 105 eells/ml in RPMI 
1640 with 2% FCS, penicillin, streptomycin, glutamine and 25 /-1M alpha 
methyl mannoside (Sigma Chemical Co.). 104 cells/well were incubated 
at 37°C in 5% CO2 for 24 hr with varying concentrations of EC SUP. 
Cultures were pulsed with 0.5 /-ICi 3H TdR for the final 6 hr of 
incubation, harvested, and counted as previously described. 
IL-2 was generated by culturing 107 C3H/HeJ spleen cells in a 24 
well Costar dish with 10% FCS, penicillin, streptomycin, glutamine and 
Con A (20/-lg/ml) for 3 days at 37°C. IL-2 so generated was then tested 
as above. In order to determine if ET AF would enhance IL-2 produc-
tion, varying amounts of EC SUP were added to the above C3H/HeJ 
spleen cell cultures and the resultant supernatant was then incubated 
with the CT6 cells and tested as above. 
RESULTS 
Dose Respense for ETAF Production 
Epidermal cells were cultured for 3 days and the cell free 
supernatant was tested at a 1: 4 dilution for its ability to 
augment PHA-induced DNA synthesis by thymocytes. Signifi-
cant activity was present in the supernatant from EC cultured 
at concentrations of 1 X 106/ml to 10 X 107/ ml. In order to 
TABLE I. Effect of epidermal cell concentration on ETAF 
~ production 
Cell concentration for production of SUP" CPM ' H TdR incorporation by C3H/HeJ thymocytes 
10 X 107/ml 
10 X 10G/ml 
7.5 X lOG/ml 
5.0 X lOG/ml 
2.5 X lOG/ml 
1.0 X lOG /m! 
1.0 X 10"/ml 
1.0 X 104/ml 
5,117 ± 980& 
8,791 ± 763 
9,151 ± 510 
6,137 ± 728 
3,656 ± 1,148 
1,207 ± 79 
None (PHA stimulated thymocytes) 
768 ± 120 
728 ± 33 
536 ± 270 
a The epidermal cells were cultured for 3 days without stimulants. 
b Mean ± SEM of cpm of 3H TdR incorporated by PHA stimulated 
thymocytes cultured for 72 hr with a 1:4 dilution of dialyzed supernatant 
from cultured epidermal cells. 
TABLE II. Titer of ETAF activity 
Dilution of SUP 
1:4 
1:8 
1:16 
1:32 
1:64 
1:128 
Background 
stimulated 
cytes) 
(PHA 
thymo-
CPM ' H TdR incorporation by C3H/HeJ 
thymocytes" 
15,347 ± 3,3~4+ 7,737 ± 1,334++ 
8,473 ± 874 3,687 ± 827 
5,392 ± 1,274 2,484 ± 473 
3,442 ± 509 1,077 ± 256 
2,599 ± 874 569 ± 108 
588 ± 114 583 ± 57 
769 ± 157 545 ± 111 
• Mean ± SEM of 3H TdR uptake by thymocytes cultured for 72 hr 
with serial two fold dilutions of supernatants of 7.5 X 106 ml unstimu-
lated murine epidermal cells grown with 10% FCS+ or without FCS++ 
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TABLE III. Kinetics of ETAF production 
Hours in culture" 
o 
2 
8 
24 
48 
72 
96 
CPM 'H TdR incorporation 
by C3H/HeJ thymocytes 
599 ± 224b 
902 ± 127 
3,940 ± 100 
5,997 ± 1,528 
6,702 ± 1,444 
7,122 ± 1,240 
2,113 ± 786 
Background (PHA stimulated thymocytes) 698 ± 195 
• Supernatant was collected from 7.5 X lOG EC/ml cultured for 
varying times and tested at a 1:4 dilution for effect on 3H TdR uptake 
by thymocytes. 
b CPM ± SEM of 3H TdR uptake by thymocytes. 
TABLE IV. Effect of LC depletion on ETAF production 
Treatment of EC %1a+" 
anti-Ia+C' 0.09 
NMS+C' 2.8 
Untreated 2.9 
Background (PHA stimulated thymo-
cytes) 
CPM .1H TdR incorporation by 
C3H/HeJ thymocytes 
11,983 ± 2,703& 
13,141 ± 1,599 
12,001 ± 3,017 
2,096 ± 198 
" Viable Langerhans cells as determined by simultaneous anti-Ia and 
ethidium bromide staining. 
b Mean ± SEM of cpm 3H TdR incorporation by thymocytes incu-
bated for 72 hr with a 1:4 dilution of supernatants obtained from the 
above groups of cultured unstimulated epidermal cells. 
detect this activity it was necessary to eliminate a small molec-
ular weight inhibitor(s) of DNA synthesis by dialyzing the SUP 
before testing. The highest levels of factor were produced by 
EC at concentrations of 7.5 X 106/ml and 10 X 106/ ml (Table 
I). At 10 X 107/ml there was a decrease in factor activity. Unless 
otherwise stated, in the following experiments the factor was 
obtained from the supernatants of cultures containing 7.5 X 
106/ml EC. The supernatant from an identical number offibro-
blasts or heat killed epidermal cells had no significant activity. 
The factor which we called epidermal cell thymocyte activating 
factor (ETAF), produced by unstimulated EC, exhibited activ-
ity to a titer of 1:64 (Table II). Although the presence offetal 
calf serum (FCS) in the medium enhanced ET AF production, 
the factor was detectable in FCS-free supernatants (Table II) . 
Kinetics for the Production of ET AF 
Supernatants of cultured EC were removed after 0, 2, 8, 24, 
48, 72 and 96 hr in culture. When obtained after 2 hr the 
supernatant did not augment thymocyte proliferation, however 
after 8 hr significant activity was present (Table III). This 
supernatant activity increased to a maximum after 48-72 hr 
and then activity began to decrease. In subsequent experiments 
supernatants were therefore obtained after 3 days of culture at 
which time cell viability was approximately 30% as determined 
by trypan blue exclusion. 
EC Depletion of Langerhans Cells 
In order to determine whether Langerhans cells (LC) were 
responsible for ET AF production, EC suspensions were de-
pleted of LC by treating the EC suspension with anti-Ia anti-
serum and complement. Normal mouse serum plus complement 
was used as a control. Using this technique it was found thp.t 
EC depleted of LC maintained ET AF production (Table IV). 
Stimulants for the Production of ET AF 
Various stimulants were tested for their effect on EC produc-
tion of ET AF. As concanavalin A, phytohemagglutinin, lipo-
polysaccharide, phorbol myristic acetate (PMA), muramyl di-
peptide (MDP) and streptolysin 0 had previously been shown 
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to stimulate IL-l production by murine macrophages [9-12], 
these agents were used in an attempt to increase ET AF pro-
duction by EC. Since all EC express H-2 antigens on their 
surface and since LC in addition express Ia antigens [16], 
attempts were made to stimulate ETAF production with anti-
sera directed against these antigens. Since cholera toxin has 
been shown to enhance the growth of cultured epidermal cells 
and keratinocytes [22], we investigated whether cholera toxin 
would stimulate ET AF production as well. Similarly, since 
epidermal growth factor (EGF) optimizes conditions for growth 
of epidermal cells we sought to determine the effect of EGF on 
the production of ET AF [23]. In all cases the stimulant was 
added to a medium control (without EC) and this was also 
tested for its effect on PHA stimulated thymocytes. There was 
no significant increase or inhibition of factor production with 
any of the above stimulants except for PMA, and MDP (Table 
V). 
PMA Pulse 
Since PMA by itself is capable of enhancing lectin induced 
thymocyte proliferation (Table V), we incubated EC for 6 h.r 
with PMA at 37°C, then washed the cells 3 times and reincu-
bated the cells in fresh medium for the next 66 hr. The SUP 
was then tested for ET AF activity. Significant enhancement of 
ET AF was produced by pulsing with PMA. Dead epidermal 
cells pulsed with PMA gave no significant ETAF activity. These 
data suggest that there was little or no PMA left in the SUP. 
Therefore, enhancement of ET AF production by the PMA 
pulse must be attributed to enhanced production or secretion 
of ETAF by viable epidermal cells (Table VI). 
Effect of Ionizing Radiation and Cycloheximide Treatment 
on ETAF Production 
When the EC were irradiated with 2000 R and then incubated 
for 3 days they produced considerably less factor than non-
irradiated EC (1,749 ± 390 vs. 9,151 ± 510, background 736 ± 
88). When protein synthesis was inhibited by cycloheximide, no 
ET AF production was detected (592 ± 122 vs background 736 
± 88 cpm). Cycloheximide added to a supernatant with known 
ET AF activity and dialyzed as before had no effect on thymo-
TABLE V. Effect of PMA" and MDP' on ETAF production 
Source of SUP 
EC stimulated with PMA (1 f.Lgm / 
ml) 
EC stimulated with MDP (10- 9 gm/ 
ml) 
EC unstimulated 
No EC (PHA stimulated thymo-
cytes) 
PMA (1 f.Lgm/ml) without EC 
MDP (10-9 gm/mll without EC 
" PMA = phorbol myristic acetate. 
b MDP = murarnyl dipeptide. 
CPM 'H TdR incorporation by 
C3H/ HeJ thymocytes 
24,287 ± 3,488c 
15,523 ± 1,426 
7,122 ± 1,240 
698 ± 195 
6,985 ± 1,741 
468 ± 79 
c Mean ± SEM of CPM of 3H TdR incorporated by thymocytes 
cultured for 72 ill with a 1:4 dilution of dialyzed supernatant from 7.5 
x lOH/ml cultured epidermal cells with or without PMA or MDP. 
TABLE VI. Enhancement of ETAF production by PMA 
Source of SUP 
PMA pulsed EC 
PMA pulsed dead EC 
EC without PMA 
Background (PHA stimulated thy-
mocytes) 
CPM 'H TdR incorporation by 
C3H/ HeJ thymocytes 
26,891 ± 869" 
2,087 ± 1,123 
14,292 ± 2,663 
2,236 ± 898 
a Mean ± SEM of 3H TdR incorporation by thymocytes cultured for 
72 ill with a 1:4 dilution of dialyzed supernatant from 7.5 x 106 
epideremal cultured cell. ' 
TABLE VII. Ammonium sulfate precipitation 
Percent Saturation (NH,h SO, 
0-25 
25-45 
45-65 
65-85 
85-100 
Background (PHA stimulated thymocytes) 
CPM "H TdR Incorpora-
tion by C3H/ HeJ thymo-
cytes 
782 ± 208" 
6,595 ± 2,106 
7,813 ± 1,178 
1,238 ± 412 
528 ± 78 
684 ± 112 
" Mean ± SEM of cpm of 3H TdR uptake by thymocytes cultured 
for 72 ill with redissolved and dialyzed ammonium sulfate precipitate 
from supernatant of epidermal cell cultures. 
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Column chromatography on Sephacryl 8-200 of 30x concentrated 
supernatants from EC. Fractions were tested at a 1: 2 dilution in the 
thymocyte proliferative assay. 
cyte proliferation. Thus, protein synthesis but not epidermal 
cell proliferation is required for production or release of ET AF. 
Biochemical Characterization of ETAF 
When increasing percentages of ammonium sulfate were 
added to ET AF and the resultant precipitate dissolved, dialyzed 
and tested for ET AF activity it was found that most activity 
was precipitated with between 25 and 65% saturation with 
ammonium sulfate (Table VII), 
The concentrated SUP was placed on a Sephacryl S-200 
column. The molecular weight of the active fraction was found 
to be in the range of 15,000 daltons (Figure), which is in the 
range ofthat of murine macrophage derived IL-l. As well, using 
a Sephadex G-50 column, the molecular weight of the active 
fraction was in the range of 15,000 daltons. 
Heating the SUP to 100°C for 10 min inactivated ET AF 
activity (2,007 ± 23 cpm compared to background of 2,236 ± 98 
cpm), but there was no change in activity after heating to 37°C 
or 57°C for 10 min (16,834 ± 1,784 cpm and 15,985 ± 2,543 cpm 
respectively) when compared to unheated supernatant (15,932 
± 2,897 cpm). 
The effect of pH was assessed by adding IN HCL or IN 
NaOH to alter the pH from 3 to 13. After 1 hr the pH was 
adjusted to 7.5 and SUP dialyzed and tested as before. No 
significant change in activity was found in samples with pH 6 
to pH 13 however some reduction was noted at pH 5 and 
activity was completely abolished at pH 3 and pH 4 (Table 
VIII). 
Simultaneous Stimulation of Thymocytes with IL-J and 
ETAF 
Supernatants of IL-l and ETAF containing submaxirnal ac-
tivity in the thymocyte assay were tested separately and to-
gether for activity in the thymocyte assay. Representative 
results as shown in Table IX indicate that IL-l and ETAF are 
not additive or synergistic. 
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TABLE VIII. Effect ef pH on ET AF production 
pH alteration of SUP 
3" 
4 
5 
6 
7 
8 
9 
10 
11 
CPM 3H TdR C3H/HeJ 
thymocytes 
498 ± 106b 
607 ± 23 
1,057 ± 23 
2,186 ± 256 
2,579 ± 98 
2,903 ± 521 
2,199 ± 628 
1,901 ± 528 
2,256 ± 255 
Background (PHA stimulated thymocytes) 528 ± 68 
"pH of SUP from 7.5 x 106 cultured EC was altered for 1 hr then 
adjusted to pH 7.5 and tested for ETAF activity. 
b Mean ± SEM of cpm 3H TdR incorporation by thymocytes cultured 
for 72 hr with a 1:4 dilution of pH altered supernatant from cultured 
epidermal cells. 
TABLE IX. Simultaneous stimulation of thymocytes with lL-1 and 
ETAF 
Factor added 
IL-l aloneb 
ETAF aloneb 
IL-1 + ETAFc 
Background (PHA stimulated thy-
mocytes) 
CPM "H TdR incorporation by 
C3H/HeJ thymocytes 
15,880 ± 1,805" 
15,392 ± 2,999 
12,242 ± 3,605 
569 ± 29 
" Mean ± SEM of CPM 3H TdR incorporation by thymocytes 
cultured for 72 hr. 
b Proliferative response to dilutions of IL-1 or ETAF yielding 50% of 
maximum activity in thymocyte assay. 
C Equal volumes of appropriate dilutions of IL-1 and ETAF were 
mixed to yield the same concentration as either factor tested alone. 
TABLE X. Enhancement of lL-2 production by ETAF 
Source of SUP" 
Con A (20 Ilg/ml)b _ 
Con A + ETAF 1:4 
Con A + ETAF 1:8 
Con A + ET AF 1:16 
ETAF 1:4 
ETAF 1:8 
ETAF 1:16 
NO STIMULANT 
Background (CT6 cells alone) 
CPM 3H TdR incorporation by 
CT 6 celJs in response to S UP 
7,547 ± 957c 
28,599 ± 875 
17,411 ± 1,158 
9,300 ± 1,140 
1,759 ± 436 
1,489 ± 736 
1,058 ± 298 
1,006 ± 347 
491 ± 89 
« C3H/HeJ spleen cells stimulated with Con A alone, ET AF alone, 
Con A plus ETAF or with no stimulant. 
b IL-2 generated by culturing 107 C3H/HeJ spleen cells for 3 days at 
37°C in the presence or absence of Con A (20 Ilg/ ml) and in the 
presence or absence of varying diLutions of ET AF and tested at a 1:4 
dilution. 
c Mean ± SEM of 3H TdR uptake by CT6 cells cultured for 24 hr 
with IL-2 alone, ET AF alone or various dilution of ET AF plus IL-2. 
lL-2 Enhancement by ETAF 
As seen in Table X, no IL-2 activity was detected when 
ET AF alone was tested in the CT6 assay. However, significant 
enhancement of IL-2 production was seen when various dilu-
tions of ET AF were added to Con A stimulated spleen cells and 
the resultant supernatant tested for activity on the IL-2 depen-' 
dent murine T-cell line (CT6 cell line) (Table X). 
DISCUSSION 
Interleukin 1 (IL-1) is a macrophage product that augments 
the PHA induced proliferation of thymocytes [1-9]. In view of 
the relationship between macrophages and epidermal Langer-
hans cells we investigated whether Langerhans cells, like mac-
rophages, produce IL-l. We found that murine epidermal cells, 
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even after depletion of Langerhans cells, produced significant 
amounts of thymocyte activating factor. Hence IL-l like 
activity may be produced by cells unrelated to those of mono_ 
cyte or macrophage lineage. Luger et al [24] have also found 
thymocyte activating factor in the supernatants of a sponta_ 
neously transformed keratinocyte cell line (Pam 212), which is 
devoid of Langerhans cells. Since this factor enhanced lectin 
induced thymocyte proliferation, the factor is called Epidermal 
Cell Thymocyte Activating Factor (ETAF). Preliminary data 
has shown that ET AF is also produced by human epidermal 
cells (SUP from 5 X 106 human EC produced 10,056 ± 1,428 
cpm 3H TdR incorporation vs background of 1,007 ± 56 cpm). 
In order to detect this factor activity, it was necessary to 
eliminate a small molecular weight inhibitor(s) of DNA synthe-
sis by dialysis. The inhibitory factor(s) was present in both 
human and murine epidermal cell supernatants. The relation_ 
ship between ET AF and this inhibitor is unknown. 
We have found that ETAF is produced by unstimulated 
epidermal cells, but considerably more ET AF is produced when 
epidermal cells are stimulated with certain chemicals or adju-
vants. While a variety of stimulants were tested for their effect 
on ET AF production only two were found to increase ET AF 
production; phorbol myristic acetate (PMA) and muramyl di-
peptide (MDP). PMA is known to be a potent inducer of IL-l 
production and release by the murine macrophage cell line 
P388D, cells [12]. Our data indicate that PMA is also capable 
of enhancing ET AF production. MDP is a synthetic analog of 
the cell wall of mycobacterium smegmatis. MDP has been 
shown to stimulate human' peripheral blood mononuclear cells 
and murine macrophages to produce IL-1 [11]. Our data indi-
cate that MDP is also capable of enhancing ET AF production. 
The mechanism(s) involved in enhanced ET AF production by 
two such diverse chemicals are unknown as are the reasons why 
other IL-1 stimulants such as LPS or Con A do not enhance 
ET AF production. 
ET AF appears not only to lack genetic restriction e.g. BALBI 
c (haplotype H-2d ) derived thymocyte activating factor is ca-
pable of stimulating C3H/HeJ (H_2k) thymocytes, but ETAF 
also lacks species specificity, e.g., ET AF derived from human 
epidermal cells is also capable of stimulating C3H/HeJ thy-
mocytes. 
ET AF derived from murine epidermal cells exhibits certain 
biological and biochemical properties similar to IL-l produced 
by murine macro phages or by the macrophage cell line P388D" 
namely both enhance lectin induced DNA synthesis in thymo-
cytes [10]. Furthermore ET AF and IL-1 have similar molecular 
weights, approximately 15,000 daltons [3-7], both are inact i-
vated by heating to lOO°C for 10 min., both are stable at a wide 
range of pH and both precipitate at approximately the same 
concentration of ammonium sulfate [10,25] . 
In order to determine whether IL-1 and ET AF were syner-
gistic, additive, or inhibitory, submaximal amounts of IL-1 and 
ETAF (concentrations yielding approximately 50% of maxi-
mum CPM in thymocyte assay) were tested, individually and 
as a mixture in increasing dilutions for activity, in the thymo-
cyte assay. The mixture of IL-1 and ETAF resulted in no 
incremen t in activity over either factor alone. Since these 
experiments were performed with crude preparations of these 
mediators, we cannot make an unequivocal statement about 
their interactions. We can only suggest that IL-l and ETAF are 
not identical. They may however, act sequentially or may have 
overlapping effects. 
We also tested whether ETAF, like IL-1, affects peripheral 
lymphocyte function as well as thymocyte proliferation. We 
investigated whether ETAF, like IL-1, enhanced interleukin 2 
production. Interleukin 2, (previously termed T cell growth 
factor) has been shown to promote the growth of T cell lines 
[20,26], to generate cytotoxic T cells [26,27] and to provide T 
cell help for enhanced antibody production by B cells [28]. 
There was no IL-2 activity in the supernatant of cultured 
epidermal cells but when ET AF was added to Con A stimulated 
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C3H/HeJ spleen cells, enhancement of IL-2 production was 
detected. Thus ETAF, by enhancing IL-2 production, can po-
tentially stimulate a variety of immunological reactions. 
The fmdings reported here thus expand the growing evidence 
that epidermal cells may interact with thymus-derived lympho-
cytes. Rubenfeld et al [29] have recently shown that epidermal 
cells and epidermal cell culture supernatants can lead to the 
expression of an early T cell differentiation marker, terminal 
deoxynucleotidyl transferase. In other studies Kato et al [30] 
have shown, by indirect immunoflorescence, that epidermal 
cells bind an antibody against serum thymic factor. The rela-
tionship between ET AF and thymic factors, however, remains 
to be studied. 
ET AF may also playa role in T cell stimulation by Langer-
hans cells. It is possible that in previous studies showing genet-
ically restricted antigen and allogeneic T cell stimulation by 
Langerhans cells, keratinocytes contributed in a secondary fash-
ion by producing ET AF [15]. Thus after the initial signal from 
Langerhans cells, ET AF may enhance the activation of sensi-
tized lymphocytes. 
The true relationship between Interleukin 1 and ET AF and 
the mode of ETAF enhancement of IL-2 production remain to 
be determined, however the fact that epidermal cells devoid of 
Langerhans cells are capable of stimulating thymocytes and 
enhancing IL-2 activity may have relevance to certain patho-
logic processes in the skin. Lymphocytic infiltration in the skin 
is seen in a wide variety of pathologic processes, both benign 
and malignant. In fact the histologic hallmark of cutaneous T 
cell lymphoma is a collection of T cells within the epidermis 
[31l In this regard it is of interest that the majority of 
cutaneous T cell lymphomas appear to represent malignancies 
of helper T cells [32,33] and, as stated earlier, IL-1 (and perhaps 
ET AF) appears to stimulate helper cells [7]. It is possible that 
ET AF by itself OJ· by its enhancement of IL-2 may play a 
significant role in the regulation of some of tl).ese disorders. 
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